Browsing: STATEMENTS

The amendment leaves the financial statements and other disclosures from the June 30, 2026 quarter unchanged.

The company attributed the delay to finalizing its financial statements and other disclosures for the year ended June 30, 2026.

The preliminary adjustments are non-cash and are estimated to reduce total equity at December 31, 2025 by approximately €3.8 million.

This is a paid press release. Contact the press release distributor directly with any inquiries.

Aug. 24, 2026 /PRNewswire/ — Aurora Cannabis Inc. (“Aurora” or the “Company”) (TSX: ACB) (NASDAQ: ACB), the leading Canadian-based global medical cannabis company, today cautioned shareholders that Curaleaf Holdings, Inc.’s (“Curaleaf”) (TSX: CURA) (OTCQX: CURLF) announcement of an unsolicited take-over bid ( “Hostile Bid”) appears to contain inaccurate statements about Aurora’s business and should be…